Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -65.86% | -24.05% | 29.46% | -512.40% | -289.43% |
| Total Depreciation and Amortization | 0.04% | -2.42% | -4.72% | -2.06% | 0.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 728.89% | 584.13% | -49.34% | 209.86% | 180.38% |
| Change in Net Operating Assets | -84.91% | -42.67% | 0.50% | 176.33% | 483.57% |
| Cash from Operations | -132.09% | -26.46% | 185.36% | -189.35% | -187.60% |
| Capital Expenditure | -188.08% | -17.55% | 52.78% | 99.39% | 99.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | 0.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.11% | 98.00% | 98.87% | 87.42% | 85.76% |
| Total Debt Issued | 0.61% | -10.85% | -25.29% | 56.55% | 346.74% |
| Total Debt Repaid | -69.51% | -67.36% | -65.27% | -40.01% | -11.09% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.09% | -86.20% | -141.91% | -29.86% | 123.45% |
| Foreign Exchange rate Adjustments | -118.31% | 14.40% | 75.95% | 44.82% | -67.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.30% | -23.87% | 81.99% | 92.92% | 94.11% |